Novel Effect of Mineralocorticoid Receptor Antagonism to Reduce Proinflammatory Cytokines and Hypothalamic Activation in Rats With Ischemia-Induced Heart Failure

Circulation Research - Tập 99 Số 7 - Trang 758-766 - 2006
Yu‐Ming Kang1,2, Zhihua Zhang1,2, Ralph F. Johnson1,2, Yang Yu1,2, Terry G. Beltz1,2, Alan Kim Johnson1,2, Robert M. Weiss1,2, Robert B. Felder1,2
1From the Departments of Internal Medicine (Y.-M.K., Z.-H.Z., Y.Y., R.M.W., R.B.F.) and Psychology (R.F.J., T.B., A.K.J.), Roy J. and Lucille A. Carver College of Medicine, University of Iowa; and Veterans Affairs Medical Center (R.M.W., R.B.F.), Iowa City.
2Veterans Affairs Medical Center (R.M.W., R.B.F.), Iowa City.

Tóm tắt

Blocking brain mineralocorticoid receptors (MRs) reduces the high circulating levels of tumor necrosis factor (TNF)-α in heart failure (HF) rats. TNF-α and other proinflammatory cytokines activate neurons in the paraventricular nucleus (PVN) of hypothalamus, including corticotropin-releasing hormone (CRH) neurons, by inducing cyclooxygenase (COX)-2 activity and synthesis of prostaglandin E 2 by perivascular cells of the cerebral vasculature. We tested the hypothesis that systemic treatment with a MR antagonist would reduce hypothalamic COX-2 expression and PVN neuronal activation in HF rats. Rats underwent coronary ligation to induce HF, confirmed by echocardiography, or sham surgery, followed by 6 weeks treatment with eplerenone (30 mg/kg per day, orally) or vehicle (drinking water). Eplerenone-treated HF rats had lower plasma TNF-α, interleukin (IL)-1β and IL-6, less COX-2 staining of small blood vessels penetrating PVN, fewer PVN neurons expressing Fra-like activity (indicating chronic neuronal activation), and fewer PVN neurons staining for TNF-α, IL-1β, and CRH than vehicle-treated HF rats. COX-2 and CRH protein expression in hypothalamus were 1.7- and 1.9-fold higher, respectively, in HF+vehicle versus sham+vehicle rats; these increases were attenuated (26% and 25%, respectively) in HF+eplerenone rats. Eplerenone-treated HF rats had less prostaglandin E 2 in cerebrospinal fluid, lower plasma norepinephrine levels, lower left ventricular end-diastolic pressure, and lower right ventricle/body weight and lung/body weight ratios, but no improvement in left ventricular function. Treatment of HF rats with anticytokine agents, etanercept or pentoxifylline, produced very similar results. This study reveals a previously unrecognized effect of MR antagonism to minimize cytokine-induced central neural excitation in rats with HF.

Từ khóa


Tài liệu tham khảo

10.1152/ajpregu.00279.2002

Brown MR, Fisher LA. Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Fed Proc. 1985; 44: 243–248.

10.1111/j.1749-6632.2000.tb05371.x

De Nicola AF, Grillo C, Gonzalez S. Physiological, biochemical and molecular mechanisms of salt appetite control by mineralocorticoid action in brain. Braz J Med Biol Res. 1992; 25: 1153–1162.

10.1016/S0192-0561(97)85556-7

10.1111/paa.1999.111.5.423

10.1111/j.1749-6632.2000.tb05426.x

10.1007/s00109-001-0289-z

10.1136/hrt.2004.046540

10.1523/JNEUROSCI.17-18-07166.1997

10.1152/ajpregu.00317.2002

10.1111/j.1365-2826.2005.01336.x

10.1046/j.1471-4159.1997.68020704.x

Fisher LA. Central actions of corticotropin-releasing factor on autonomic nervous activity and cardiovascular functioning. Ciba Found Symp. 1993; 172: 243–253.

10.1152/ajpregu.00254.2003

10.1016/j.cardiores.2005.03.001

10.1152/ajpregu.00027.2003

10.1152/ajpheart.01072.2003

10.1152/ajpregu.00376.2002

10.1152/ajpheart.2001.281.5.H2241

10.1152/ajpregu.2001.281.5.R1734

10.1152/ajpheart.00099.2004

10.1006/frne.1997.0157

10.1113/jphysiol.1979.sp012688

10.1152/ajpheart.00840.2004

10.1016/S0006-8993(99)01937-X

10.1016/j.cardiores.2006.01.013

Kang Y-M, Zhou R, Zheng W, Tomanek R, Felder RB. Pre-treatment with etanercept inhibits full expression of the pro-inflammatory cytokine cascade following acute myocardial infarction. FASEB J. 2005; 19: A1289 Abstract.

10.1016/S0169-328X(02)00353-4

10.1016/S0162-3109(00)00249-6

10.1046/j.1525-1373.2000.22304.x

10.1124/jpet.301.2.418

10.1523/JNEUROSCI.22-13-05606.2002

10.1007/s00395-003-0431-x

10.1146/annurev.cb.10.110194.002201

10.1152/physrev.1999.79.1.1

Voisin L, Breuille D, Ruot B, Ralliere C, Rambourdin F, Dalle M, Obled C. Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats. Am J Physiol. 1998; 275: R1412–R1419.

10.1254/fpj.124.83

10.1152/ajpregu.00406.2002

10.1152/ajpheart.00473.2004

10.1016/j.pbiomolbio.2003.11.010

Thông tin
Thông tin xuất bản

Circulation Research

Tập 99 Số 7

758-766

Thông tin tác giả